CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Prakt. Lék., 2006, 86, No. 2, p. 71-77.
 
The long pentraxin PTX3 - a new acute phase reactant 
KUNEŠ P.i, KREJSEK J.2 

1Kardiochirurgická klinika LF UK a FN Hradec Králové,přednosta doc. MUDr. J. Harrer, CSc.2Ustav klinické imunologie a alergologie LF UKa FN Hradec Králové, přednosta MUDr. Otakar Kopecký, CSc.
 


Summary:

       Pentraxin 3 is a novel protein of the acute phase response which shares a striking degree of homology with the well-known pentraxin C-reactive protein. Whereas CRP is made up in the liver and its effects are disse-minated systemically to the whole body, PTX3 is produced directly within the inflammatory focus and its effects are targeted to the inflamed tissue. Both pentraxins share the ability to activate complement via the classical pathway. Both PTX3 and CRP také part in the pathogenesis of some inflammatory diseases featu-ring an autoimmune component. In this respect, atherosclerosis including its complications represents a pa-thological condition that evokes much interest nowadays. This review article presents recently discovered effects of PTX3 in the pathogenesis of rheumatoid arthritis, the IgA nephropathy and atherosclerosis, with speciál emphasis being laid on the prognostic value of PTX3 in patients suffering from acute myocardial infaretion, septic shock and pulmonary form of tuberculosis.

        Key words: pentraxin 3 - C-reactive protein - macrophages - endothelial cells - inflammatory response.
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER